Dawson James Downgrades Aditxt to Neutral

Dawson James analyst Jason Kolbert downgrades Aditxt (NASDAQ:ADTX) from Buy to Neutral.

Dawson James analyst Jason Kolbert downgrades Aditxt (NASDAQ:ADTX) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy

Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of CBD

MJNA